An elevated serum iron is commonly found in patients with infectious hepatitis (1-4) and evidence has been presented (5, 6) that acute hepatocellular necrosis, regardless of its etiology, is invariably accompanied by a rise in serum iron. A close time relationship between elevation of the serum iron and actual disintegration of liver cells has been found (6), and the hyperferremia has been attributed to a release of storage iron from the dying liver cells. As the iron is largely stored in the liver as ferritin, it was of interest to investigate whether ferritin is released into the peripheral blood of patients with acute hepatocellular disease, while it could not be demonstrated in the blood of normal individuals (7).
An elevated serum iron is commonly found in patients with infectious hepatitis (1-4) and evidence has been presented (5, 6 ) that acute hepatocellular necrosis, regardless of its etiology, is invariably accompanied by a rise in serum iron. A close time relationship between elevation of the serum iron and actual disintegration of liver cells has been found (6) , and the hyperferremia has been attributed to a release of storage iron from the dying liver cells. As the iron is largely stored in the liver as ferritin, it was of interest to investigate whether ferritin is released into the peripheral blood of patients with acute hepatocellular disease, while it could not be demonstrated in the blood of normal individuals (7) .
Mazur, Shorr, and Baez (8) (9) (10) have reported the presence of VDM, which is said to be identical with ferritin, in the peripheral blood in several conditions including hepatic cirrhosis, congestive heart failure and shock. The concentrations of this vasoactive material were so minute that their detection required the use of the mesoappendix bioassay. We were, in this study, concerned with a possible relationship between serum iron rise and the release of ferritin iron from the necrotic liver cells. The serum iron increases in such patients are in the order of one hundred to several hundred micrograms per hundred cc. of serum. If ferritin iron contributes to any significant extent to this serum iron increase, its concentration in the peripheral blood would be measurable by chemical methods after separation of the ferritin from the beta,-globulin bound iron. This separation was accomplished by precipitation of the ferritin by means of an antiferritin immune serum.
Mazur and Shorr (8) have shown that the iron content of ferritin is not altered when the protein moiety of ferritin is precipitated by means of an antibody. Ferritin iron in the serum, at concentrations we were interested in in this study, can, therefore, be measured by chemical determination of iron in the precipitate.
METHODS
Crystalline ferritin-apoferritin was prepared from human liver tissue (autopsy material) according to the method of Granick (7) . The crude ferritin was recrystallized five times with CdSO4, reprecipitated at 50 per cent saturation with (NH4),SO4, and dialyzed against tap water for 24 hours. At that time the preparation was usually free of NH4 ions.
The antiserum was prepared according to the procedure of Mazur and Shorr (8) . Rabbits were injected intravenously with aluminum precipitated human ferritin over a period of four weeks. Each animal received a total of 4.4 mg. of antigen nitrogen, and thereafter booster injections of 0.15 mg. of antigen nitrogen. The antisera were chilled, sharply centrifuged and pooled. The antiferritin titer of the antiserum was determined by adding known amounts of ferritin dissolved in human serum to one cc. of the 1: 10 diluted antiserum. The mixture was incubated for one hour at 370 C. and stored for three days at 40 C. The tubes were then centrifuged, the precipitate washed with chilled saline, and the iron and nitrogen in the precipitate were measured. The supernatant was tested for excess of antigen or antibody.
The iron content of ferritin was measured by Scott's method (11) . Other iron methods employed were the methods of Wong (12) , of Barkan and Walker (13) and a modification of the latter as described below.
The ferritin determination in the blood of patients was carried out in the following manner: The blood was collected in iron free tubes and the serum was sharply centrifuged to remove all red cells. Four cc. of this serum was added to 0.3 of antiserum, to 0.3 of 1: 3 diluted antiserum, and to 0.3 cc. of normal rabbit serum, respectively.
After one hour of incubation at 370 C. and three days' storage at 4°C., the tubes were centrifuged. When ferritin was present, a distinct brownish precipitate could be noted in the antiserum tubes. The supernatant was decanted and that of the tube containing the undiluted antiserum was tested for excess of antigen. If ferritin was present in the supernatant, suitable serum dilutions were used in a repetition of the test until quantitative precipitation was obtained.
After washing of the precipitate with chilled iron free saline it was taken up in 3 cc. of 3 N HCI and allowed to stand at 370 C. for 24 hours for a complete removal of iron from the apoferritin. Thereafter one cc. of 20 per cent trichloracetic acid was added under constant shaking. After one hour the tubes were centrifuged, and to 2 cc. amounts of iron in the precipitate is rather inaccurate and subject to contamination, and it was not the aim of this study to detect minimal ferritin concentrations in the patients' serum. The term "no ferritin," used in the presentation of the results, thus refers to the absence of ferritin, above the concentration of 20 ,ug. per cent ferritin iron, and likewise the term ferritinemia, as used in this paper, indicates the presence of ferritin above this concentration.
The validity of the ferritin determination in serum by measuring the iron content of the precipitate depends furthermore upon the specificity of the antiserum, i.e., the antiserum must not, directly or indirectly, precipitate other iron containing compounds of the serum, viz., beta,-globulin iron, iron in excess of the iron binding capacity of the serum or hemoglobin iron. When hemoglobin was added to ferritin containing serum, the iron recovery in the precipitate was not affected by hemoglobin concentrations high enough to produce a distinct coloring of the serum (approximately 0.8 mg. per cent hemoglobin Fe). The effect of non-ferritin serum iron, within or in ex- a moderately jaundiced patient with carbon tetrachloride intoxication. The liver biopsy showed in this patient a moderate degree of hepatocellular involvement and the intoxication was mainly manifested in a severe nephrosis. No ferritin was found in a patient with severe jaundice due to thorazine medication. The liver biopsy showed in this patient very little hepatocellular damage, but a marked bile-stasis in smaller bile ducts. As seen in Table IV , ferritin was found in the peripheral blood of eight patients with viral hepatitis during the first ten days of the disease. Thereafter the ferritin disappeared from circulation while the serum iron remained elevated. No correlation was detected between the presence of ferritin and liver function tests listed in Table IV . In nine other patients with viral hepatitis, ferritin was not found at any time during the disease, although the serum iron elevation in these patients was similar to those listed in Table IV. Frequent observations on pulse rate, blood pressure, EKG and urinary output were made in these two groups of viral hepatitis patients with or without ferritinemia. Neither from these measurements nor from general clinical observation was any circulatory effect noted that could be attributed in these patients to the presence of ferritin in the circulating blood.
4 (Table V) : The most persistent ferritinemia was found in six out of six patients with Hodgkin's disease involving the liver. It will be noted that in these patients the ferritin iron accounts for most if not all of the observed hyperferremia. Patient J. B. (Table V) had jaundice of two years' duration, and at the day of his death 415 ug. per cent ferritin iron was found in his blood and a serum iron of 446 Mg. per cent. The liver showed extensive necroses in centrolobular areas, hemosiderin in these areas and in Kupffer cells, and a slight increase in the portal fibrous tissue. Patient W. F. had received x-ray therapy, including the liver, and 583 Mg. per cent ferritin iron was found on the day the therapy was discontinued. Ferritin and serum iron declined on subsequent examinations but rose again to 686 Mg. per cent ferritin iron before death. The liver presented an almost identical picture as in the aforementioned patient. In patient C. G. the jaundice became more marked and the appearance of ferritin was noted subsequent to nitrogen mustard therapy. The patient succumbed several days later, and massive necroses were found in the liver which showed a diffuse periportal infiltration with lymphogranulomatous tissue. In patient C. E. an increase of the already elevated serum iron and ferritin levels will be noted following nitrogen mustard therapy. Prior to his death the serum iron was only 106 Mg. per cent while 65 Mug. per cent ferritin iron were found in the serum. The liver showed a moderate degree of fresh hepatocellular necrosis. In patient C. S. significant amounts of ferritin were found, although the patient did not show at that time any evidence of hepatic involvement. He was discharged, became jaundiced four weeks later and died eight weeks after his discharge. No autopsy was obtained.
In contrast to these patients with Hodgkin's disease of the liver who all showed a pronounced ferritinemia, no ferritin (or elevation of serum iron) was found in two patients with sarcoidosis of the liver, although both these patients had extreme enlargement of liver and spleen. Likewise no ferritin was found in three cases of carcinomatosis of the liver.
In view of the marked ferritinemia found in patients with Hodgkin's disease of the liver, 14 patients with proven Hodgkin's disease, but with no evidence of liver involvement were studied over a period of more than one year. In all of these patients low serum iron values were found, ranging from 26 to 128 jug. per cent (mean 66 ,ug. per cent), and in no instance was ferritin present in the serum. Six of these patients were autopsied and the liver was found free of granulomatous infiltration. Three of these patients had received nitrogen mustard therapy, but no ferritin or significant serum iron changes were found during or after its administration.
C) The disappearance rate of ferritin from the circulation Considering the release of ferritin from the dying liver cells as the source of the ferritin found in the blood of patients with acute hepatocellular necrosis, it was of interest to obtain information on the disappearance rate of ferritin from the circulation. In view of the possible viral contamination of the ferritin prepared from a large number of human livers, no experiments were carried out in human patients. The human ferritin was, therefore, injected intravenously in dogs and the ferritin level in the blood was followed, although it was realized that these experiments would not necessarily indicate the disappearance rate of autogenous ferritin in humans. Following injection of ferritin, the ferritin was quantitatively precipitated in the serum samples and the iron content in the supernatant serum is referred to as beta,-globulin bound iron in Figure 1 .
As seen in Figure 1 , there was in both experiments a rather fast disappearance of ferritin from the circulation during the first hour. Thereafter the disappearance rate amounted to about 50 per cent in twenty-four hours. No significant changes in the beta,-globulin bound iron were seen, indicating that no splitting of the iron from the ferritin molecule and subsequent binding of the free iron by beta,-globulin occurred in the blood stream.
In both experiments, blood pressure (recorded by strain gauge in femoral artery) and EKG were recorded continuously before, during and for a period of 60 minutes after the injections of ferritin. No changes were found.
DISCUSSION
In all patients, where ferritin was found in the peripheral blood, acute was measured in this patient, and at autopsy 24 hours later the liver was found to be nearly completely necrotic. However, less than one-half of the patients with viral hepatitis showed measurable amounts of ferritin in the blood, although by general clinical appearance and liver function tests, the disease was no less severe in patients who did not have any ferritin in the blood. In some of these patients, serum iron and serum ferritin were followed daily beginning at the first day of jaundice. While the beta,-globulin iron became greatly elevated in the course of the disease, no ferritin was found at any time, indicating that the hyperferremia commonly seen in hepatocellular necrosis is not necessarily related to a release of ferritin in concentrations that can be detected by the precipitation method used in this study.
Lack of functioning liver cells, e.g., in patients with advanced cirrhosis, was not accompanied by elevations in beta,-globulin iron or ferritin iron in the plasma. It seems, therefore, that elevation in beta,-globulin iron and appearance of ferritin in the blood depend on acute injury of liver cells, and that the damaged liver cell may either release ferritin or iron. It is possible that during rapid cell destruction the ferritin leaves the cell as such, while in a slowly degenerating cell the ferritin iron is released by a mechanism described by Mazur, Baez, and Shorr (14) . These authors found in dogs during drastic hemorrhagic hypotension a progressive transfer of ferrous iron from sulfhydryl-ferrous-ferritin in the hypoxic liver to the plasma, where it combined with the beta,-globulin.
No entirely satisfactory explanation can be offered of the markedly high ferritin concentrations found in all patients with Hodgkin's disease of the liver. Acute hepatocellular necrosis was found at autopsy or biopsy in all of these cases, but the impression was gained that the ferritinemia in these patients was unusually high and persistent compared to the extent of hepatocellular necrosis. Furthermore the ferritin iron accounted for most or all of the elevation in serum iron, i.e., the beta1-globulin iron was not significantly elevated. This is in contrast to the patients with viral or toxic hepatitis where the beta1-globulin iron was always considerably elevated in addition to the hyperferremia produced by the ferritin iron. Sarcoid or cancer metastases of the liver did not produce ferritinemia and likewise not Hodgkin's disease per se, i.e., without liver involvement. Nitrogen mustard or roentgen therapy was accompanied or followed by an increase in circulating ferritin only in those patients who had lymphogranulomatous infiltration of the liver. Haley, Andem, Riley, and Williams ( 15, 16) found significant concentrations of vasoactive ferritin in the blood of animals following irradiation with lethal or near lethal doses, but it is likely that the mechanism of this ferritin release differed from that seen after therapeutic doses in the patients with Hodgkin's disease.
No obvious pathophysiological effects of the circulating ferritin were observed. In the two experiments where considerable amounts of purified human ferritin were injected into dogs, no changes in EKG or arterial pressure were noted, the latter finding being in accordance with earlier observations of Baez, Mazur, and Shorr (17 
